Sfoglia per Autore
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
2021-01-01 Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P.
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit
2021-01-01 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T.
Treatment of Advanced Metastatic Melanoma
2021-01-01 Quaglino, Pietro; Fava, Paolo; Tonella, Luca; Rubatto, Marco; Ribero, Simone; Fierro, Maria Teresa
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications
2021-01-01 Pileri A.; Guglielmo A.; Grandi V.; Violetti S.A.; Fanoni D.; Fava P.; Agostinelli C.; Berti E.; Quaglino P.; Pimpinelli N.
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era
2021-01-01 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
Immunotherapy in transplanted patients: A special population that can no longer be ignored
2021-01-01 Rubatto M.; Merli M.; Agostini A.; Avallone G.; Mastorino L.; Fava P.; Biancone L.; Rossetti M.; Fierro M.T.; Ribero S.; Quaglino P.
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
2021-01-01 Quaglino P.; Fava P.; Pileri A.; Grandi V.; Sanlorenzo M.; Panasiti V.; Guglielmo A.; Alberti-Violetti S.; Novelli M.; Astrua C.; Rubatto M.; Tonella L.; Berti E.; Pimpinelli N.; Osella Abate S.; Fierro M.T.; Vermeer M.; Scarisbrick J.J.; Ribero S.
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience
2021-01-01 Cariti C.; Merli M.; Avallone G.; Rubatto M.; Marra E.; Fava P.; Caliendo V.; Picciotto F.; Gualdi G.; Stanganelli I.; Fierro M.T.; Ribero S.; Quaglino P.
Perspectives of immunotherapy in non-melanoma skin cancers
2021-01-01 Rubatto M.; Fava P.; Avallone G.; Agostini A.; Mastorino L.; Merli M.; Ribero S.; Quaglino P.
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials
2021-01-01 Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P.
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study)
2021-01-01 Quaglino, P; Prince, H M; Cowan, R; Vermeer, M; Papadavid, L; Bagot, M; Servitjie, O; Berti, E; Guenova, E; Stadler, R; Querfeld, C; Busschots, A M; Hodak, E; Patsatsi, A; Sanches, J; Maule, M; Yoo, J; Kevin, M; Fava, P; Ribero, S; Zocchi, L; Rubatto, M; Fierro, M T; Wehkamp, U; Marshalko, M; Mitteldorf, C; Akilov, O; Ortiz-Romero, P; Estrach, T; Vakeva, L; Enz, P A; Wobser, M; Bayne, M; Jonak, C; Rubeta, M; Forbes, A; Bates, A; Battistella, M; Amel-Kashipaz, R; Vydianath, B; Combalia, A; Georgiou, E; Hauben, E; Hong, E K; Jost, M; Knobler, R; Amitay-Laish, I; Miyashiro, D; Cury-Martins, J; Martinez, X; Muniesa, C; Prag-Naveh, H; Nikolaou, V; Quint, K; Ram-Wolff, C; Rieger, K; Stranzenbach, R; Szepesi, Á; Alberti-Violetti, S; Felicity, E; Cerroni, L; Kempf, W; Whittaker, S; Willemze, R; Kim, Y; Scarisbrick, J J
Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient
2020-01-01 Quaglino P.; Fava P.; Cariti C.; Ortoncelli M.; Aimetti M.; Milan A.; Dapavo P.; Tonella L.; Ribero S.; Fierro M.T.
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients
2020-01-01 Zocco D.; Bernardi S.; Novelli M.; Astrua C.; Fava P.; Zarovni N.; Carpi F.M.; Bianciardi L.; Malavenda O.; Quaglino P.; Foroni C.; Russo D.; Chiesi A.; Fierro M.T.
Epidemiology, Prevention and Clinical Diagnosis of Melanoma
2020-01-01 Pietro Quaglino, Paolo Fava, Paolo Broganelli, Lorenza Burzi, Elena Marra, Simone Ribero, Maria Teresa Fierro
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit
2020-01-01 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Agostini A.; Tonella L.; Ribero S.; Fierro M.T.
Lack of detection of Cutavirus DNA using PCR real time in cutaneous T-cell lymphomas
2020-01-01 Bergallo M.; Dapra V.; Fava P.; Ponti R.; Calvi C.; Fierro M.T.; Quaglino P.; Galliano I.; Montanari P.
Clinical and pathological relevance of drug-induced vitiligo in patients treated for metastatic melanoma with anti-PD1 or BRAF/MEK inhibitors
2020-01-01 Ramondetta A.; Ribero S.; Conti L.; Fava P.; Marra E.; Broganelli P.; Caliendo V.; Picciotto F.; Guida M.; Ierro M.T.; Quaglino P.
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19
2020-01-01 Pala L.; Conforti F.; Saponara M.; De Pas T.; Giugliano F.; Omodeo Sale E.; Jemos C.; Rubatto M.; Agostini A.; Quaglino P.; Fava P.; Fierro M.T.; Queirolo P.
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study
2019-01-01 Pileri A.; Fava P.; Fuligni F.; Gunnella S.; Guglielmo A.; Astrua C.; Grandi V.; Simontacchi G.; Patrizi A.; Quaglino P.; Pimpinelli N.
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
2019-01-01 Pistillo, Maria Pia*; Fontana, Vincenzo; Morabito, Anna; Dozin, Beatrice; Laurent, Stefania; Carosio, Roberta; Banelli, Barbara; Ferrero, Francesca; Spano, Laura; Tanda, Enrica; Ferrucci, Pier Francesco; Martinoli, Chiara; Cocorocchio, Emilia; Guida, Michele; Tommasi, Stefania; De Galitiis, Federica; Pagani, Elena; Antonini Cappellini, Gian Carlo; Marchetti, Paolo; Quaglino, Pietro; Fava, Paolo; Osella-Abate, Simona; Ascierto, Paolo Antonio; Capone, Mariaelena; Simeone, Ester; Romani, Massimo; Spagnolo, Francesco; Queirolo, Paola
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives | 2021 | Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P. | |
| Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit | 2021 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T. | |
| Treatment of Advanced Metastatic Melanoma | 2021 | Quaglino, Pietro; Fava, Paolo; Tonella, Luca; Rubatto, Marco; Ribero, Simone; Fierro, Maria Teresa | |
| The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications | 2021 | Pileri A.; Guglielmo A.; Grandi V.; Violetti S.A.; Fanoni D.; Fava P.; Agostinelli C.; Berti E.; Quaglino P.; Pimpinelli N. | |
| Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era | 2021 | Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone | |
| Immunotherapy in transplanted patients: A special population that can no longer be ignored | 2021 | Rubatto M.; Merli M.; Agostini A.; Avallone G.; Mastorino L.; Fava P.; Biancone L.; Rossetti M.; Fierro M.T.; Ribero S.; Quaglino P. | |
| Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome | 2021 | Quaglino P.; Fava P.; Pileri A.; Grandi V.; Sanlorenzo M.; Panasiti V.; Guglielmo A.; Alberti-Violetti S.; Novelli M.; Astrua C.; Rubatto M.; Tonella L.; Berti E.; Pimpinelli N.; Osella Abate S.; Fierro M.T.; Vermeer M.; Scarisbrick J.J.; Ribero S. | |
| Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience | 2021 | Cariti C.; Merli M.; Avallone G.; Rubatto M.; Marra E.; Fava P.; Caliendo V.; Picciotto F.; Gualdi G.; Stanganelli I.; Fierro M.T.; Ribero S.; Quaglino P. | |
| Perspectives of immunotherapy in non-melanoma skin cancers | 2021 | Rubatto M.; Fava P.; Avallone G.; Agostini A.; Mastorino L.; Merli M.; Ribero S.; Quaglino P. | |
| Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials | 2021 | Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P. | |
| Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) | 2021 | Quaglino, P; Prince, H M; Cowan, R; Vermeer, M; Papadavid, L; Bagot, M; Servitjie, O; Berti, E; Guenova, E; Stadler, R; Querfeld, C; Busschots, A M; Hodak, E; Patsatsi, A; Sanches, J; Maule, M; Yoo, J; Kevin, M; Fava, P; Ribero, S; Zocchi, L; Rubatto, M; Fierro, M T; Wehkamp, U; Marshalko, M; Mitteldorf, C; Akilov, O; Ortiz-Romero, P; Estrach, T; Vakeva, L; Enz, P A; Wobser, M; Bayne, M; Jonak, C; Rubeta, M; Forbes, A; Bates, A; Battistella, M; Amel-Kashipaz, R; Vydianath, B; Combalia, A; Georgiou, E; Hauben, E; Hong, E K; Jost, M; Knobler, R; Amitay-Laish, I; Miyashiro, D; Cury-Martins, J; Martinez, X; Muniesa, C; Prag-Naveh, H; Nikolaou, V; Quint, K; Ram-Wolff, C; Rieger, K; Stranzenbach, R; Szepesi, Á; Alberti-Violetti, S; Felicity, E; Cerroni, L; Kempf, W; Whittaker, S; Willemze, R; Kim, Y; Scarisbrick, J J | |
| Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient | 2020 | Quaglino P.; Fava P.; Cariti C.; Ortoncelli M.; Aimetti M.; Milan A.; Dapavo P.; Tonella L.; Ribero S.; Fierro M.T. | |
| Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients | 2020 | Zocco D.; Bernardi S.; Novelli M.; Astrua C.; Fava P.; Zarovni N.; Carpi F.M.; Bianciardi L.; Malavenda O.; Quaglino P.; Foroni C.; Russo D.; Chiesi A.; Fierro M.T. | |
| Epidemiology, Prevention and Clinical Diagnosis of Melanoma | 2020 | Pietro Quaglino, Paolo Fava, Paolo Broganelli, Lorenza Burzi, Elena Marra, Simone Ribero, Maria Teresa Fierro | |
| Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit | 2020 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Agostini A.; Tonella L.; Ribero S.; Fierro M.T. | |
| Lack of detection of Cutavirus DNA using PCR real time in cutaneous T-cell lymphomas | 2020 | Bergallo M.; Dapra V.; Fava P.; Ponti R.; Calvi C.; Fierro M.T.; Quaglino P.; Galliano I.; Montanari P. | |
| Clinical and pathological relevance of drug-induced vitiligo in patients treated for metastatic melanoma with anti-PD1 or BRAF/MEK inhibitors | 2020 | Ramondetta A.; Ribero S.; Conti L.; Fava P.; Marra E.; Broganelli P.; Caliendo V.; Picciotto F.; Guida M.; Ierro M.T.; Quaglino P. | |
| Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 | 2020 | Pala L.; Conforti F.; Saponara M.; De Pas T.; Giugliano F.; Omodeo Sale E.; Jemos C.; Rubatto M.; Agostini A.; Quaglino P.; Fava P.; Fierro M.T.; Queirolo P. | |
| Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study | 2019 | Pileri A.; Fava P.; Fuligni F.; Gunnella S.; Guglielmo A.; Astrua C.; Grandi V.; Simontacchi G.; Patrizi A.; Quaglino P.; Pimpinelli N. | |
| Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study | 2019 | Pistillo, Maria Pia*; Fontana, Vincenzo; Morabito, Anna; Dozin, Beatrice; Laurent, Stefania; Carosio, Roberta; Banelli, Barbara; Ferrero, Francesca; Spano, Laura; Tanda, Enrica; Ferrucci, Pier Francesco; Martinoli, Chiara; Cocorocchio, Emilia; Guida, Michele; Tommasi, Stefania; De Galitiis, Federica; Pagani, Elena; Antonini Cappellini, Gian Carlo; Marchetti, Paolo; Quaglino, Pietro; Fava, Paolo; Osella-Abate, Simona; Ascierto, Paolo Antonio; Capone, Mariaelena; Simeone, Ester; Romani, Massimo; Spagnolo, Francesco; Queirolo, Paola |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile